ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Timing of Transcranial Direct Current Stimulation (tDCS) for Enhancing Learning During Cognitive Training

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01339585
Recruitment Status : Completed
First Posted : April 20, 2011
Last Update Posted : August 12, 2014
Sponsor:
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales

Brief Summary:
This project will investigate a novel strategy for enhancing cognitive training (CT). Specifically, the investigators aim to combine a non-invasive form of brain stimulation (tDCS) with CT. This study will examine the optimal time interval - whether tDCS should be administered either before or during CT.

Condition or disease Intervention/treatment Phase
Effects on Learning Device: Transcranial direct current stimulation (tDCS) Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: The Effect of Timing of Transcranial Direct Current Stimulation (tDCS) for Enhancing Learning During Cognitive Training
Study Start Date : May 2011
Actual Primary Completion Date : May 2014

Arm Intervention/treatment
Experimental: Timing of tDCS Device: Transcranial direct current stimulation (tDCS)
Eldith Direct Current Stimulator (NeuroConn GmbH, Germany)

Experimental: Alternative timing of tDCS Device: Transcranial direct current stimulation (tDCS)
Eldith Direct Current Stimulator (NeuroConn GmbH, Germany)




Primary Outcome Measures :
  1. Change in performance across each condition. [ Time Frame: Over 2 days, with each condition conducted 1 month apart. ]
    D prime, number of correct responses, and number of errors.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Participants will be healthy right-handed subjects aged 18 to 40 years.

Exclusion Criteria:

  • Concurrent medication likely to affect mental performance,
  • Current history of drug or alcohol abuse or dependence,
  • Any psychiatric or neurological disorder,
  • Recent head injury, or history of seizure or stroke.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01339585


Locations
Australia, New South Wales
School of Psychiatry
Sydney, New South Wales, Australia
Sponsors and Collaborators
The University of New South Wales

Responsible Party: Melissa Pigot, Research Assistant, The University of New South Wales
ClinicalTrials.gov Identifier: NCT01339585     History of Changes
Other Study ID Numbers: HREC 11064
First Posted: April 20, 2011    Key Record Dates
Last Update Posted: August 12, 2014
Last Verified: August 2014